HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Oral granisetron prevents postoperative vomiting in children.

Abstract
We have studied the efficacy of granisetron, a selective 5-hydroxytryptamine type 3 receptor antagonist, administered orally for the prevention of postoperative vomiting after tonsillectomy in children. In a randomized, double-blind, placebo-controlled study, 160 paediatric patients, ASA 1, aged 4-10 yr, received placebo or granisetron (20, 40 or 80 micrograms kg-1) (n = 40 each) orally, 1 h before surgery. A standard general anaesthetic technique was used throughout. A complete response, defined as no emesis and no need for another rescue antiemetic during the first 24 h after anaesthesia, occurred in 40%, 48%, 85% and 90% of patients who had received placebo, or granisetron 20, 40 or 80 micrograms kg-1, respectively (P < 0.05; overall Fisher's exact probability test). There were no clinically important adverse events. We conclude that preoperative oral granisetron, in doses more than 40 micrograms kg-1, was effective for the prevention of postoperative vomiting in children.
AuthorsY Fujii, H Toyooka, H Tanaka
JournalBritish journal of anaesthesia (Br J Anaesth) Vol. 81 Issue 3 Pg. 390-2 (Sep 1998) ISSN: 0007-0912 [Print] ENGLAND
PMID9861127 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Retracted Publication)
Chemical References
  • Antiemetics
  • Serotonin Antagonists
  • Granisetron
Topics
  • Administration, Oral
  • Antiemetics (administration & dosage)
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Granisetron (administration & dosage)
  • Humans
  • Male
  • Postoperative Nausea and Vomiting (prevention & control)
  • Serotonin Antagonists (administration & dosage)
  • Tonsillectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: